TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17368328

Group type: EXPERIMENTAL
Intervention: Negative response to cold testing prior to RCT
Number of subjects: 83

Group type: COMPARATOR
Intervention: Sham cold test after demonstrating soft tissue signs
Number of subjects: 83
Study: 14751571

Group type: EXPERIMENTAL
Intervention: GLP-2 injection
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 11599686

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted influenza vaccine (FLU-AD; n = 204)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Conventional subunit influenza vaccine (AGRIPPAL S1; n = 104)
Number of subjects: 308
Study: 9844794

Group type: EXPERIMENTAL
Intervention: Pergolide (mean final dose, 2.8 mg daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Levodopa (mean final dose, 435 mg daily)
Number of subjects: 20
Study: 7986226

Group type: EXPERIMENTAL
Intervention: Antibodies to histone (H2A-H2B)-DNA complexes in patients with scleroderma-related disorders
Number of subjects: 150

Group type: COMPARATOR
Intervention: Antibodies to histone (H2A-H2B)-DNA complexes in patients with systemic lupus erythematosus (SLE)
Number of subjects: 150
Study: 2929803

Group type: EXPERIMENTAL
Intervention: Soap-opera style videotape intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coupon redemption for free condoms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no videotape)
Number of subjects: 0
Study: 31813108

Group type: EXPERIMENTAL
Intervention: Gluten-Free and Casein-Free (GFCF) diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal diet (including gluten and casein)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: GFCF diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal diet
Number of subjects: 37
Study: 29529627

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: CAS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 28107765

Group type: EXPERIMENTAL
Intervention: Full‐spectrum colonoscopy (FSC)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Conventional colonoscopy with right‐colon retroflexion (CC/R)
Number of subjects: 220
Study: 25820017

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Infliximab (IFX)
Number of subjects: 168
Study: 22786764

Group type: EXPERIMENTAL
Intervention: FOLFOX (combined leucovorin, 5-fluoruracil, and oxaliplatin)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: XELOX (combined capecitabine and oxaliplatin)
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Acute OXLIPN symptoms
Number of subjects: 170
Study: 20445570

Group type: EXPERIMENTAL
Intervention: Amlodipine + Angiotensin II receptor blocker
Number of subjects: 13542

Group type: EXPERIMENTAL
Intervention: Amlodipine + Diuretics
Number of subjects: 13542
Study: 18460481

Group type: EXPERIMENTAL
Intervention: Fish oil (2 capsules of 1 gm per day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Flaxseed oil (2 capsules of 1 gm per day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Hempseed oil (2 capsules of 1 gm per day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (2 capsules of 1 gm per day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: All interventions (Fish oil, Flaxseed oil, Hempseed oil, Placebo)
Number of subjects: 86
Study: 16539558

Group type: EXPERIMENTAL
Intervention: Kurasper F adhesive resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Light Bond adhesive resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Super Bond C&B adhesive resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transbond XT adhesive resin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Porcelain Liner M
Number of subjects: 0

Group type: COMPARATOR
Intervention: All adhesive resins
Number of subjects: 0
Study: 14674902

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 100 mg twice a day
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Sparfloxacin 200 mg day‐1
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Enoxacin 200 mg three times a day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Levofloxacin 100 mg three times a day
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Sitafloxacin 50 mg twice a day
Number of subjects: 57
Study: 10553854

Group type: EXPERIMENTAL
Intervention: Group A: sevoflurane anesthesia via an airway endoscopy mask
Number of subjects: 100

Group type: COMPARATOR
Intervention: Group B: total IV anesthesia with propofol, fentanyl, atracurium
Number of subjects: 100
Study: 9118417

Group type: EXPERIMENTAL
Intervention: Perivesical fat closure
Number of subjects: 89

Group type: COMPARATOR
Intervention: No fat closure
Number of subjects: 89
Study: 1864532

Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg at night
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ranitidine 150 mg at night
Number of subjects: 200
Study: 6309436

Group type: EXPERIMENTAL
Intervention: Amiloride (10-40 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: MK-421 (10 mg/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (50 mg/day) plus MK-421 (10 mg/day)
Number of subjects: 15
Study: 30630455

Group type: EXPERIMENTAL
Intervention: Psychological distress indicators
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Suicidal ideation
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Feeling down, depressed or hopeless
Number of subjects: 1191

Group type: EXPERIMENTAL
Intervention: Having no hope for the future
Number of subjects: 1191
Study: 28421646

Group type: EXPERIMENTAL
Intervention: 10-week intervention programme targeting 10 cross-curriculum words
Number of subjects: 35
Study: 27052071

Group type: EXPERIMENTAL
Intervention: Long-axis ultrasound-guided cannulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Short-axis ultrasound-guided cannulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diameter of IJ vein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Margin of safety
Number of subjects: 0
Study: 23792711

Group type: EXPERIMENTAL
Intervention: 3-month group intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: individual-enhanced standard-of-care condition
Number of subjects: 80
Study: 27933598

Group type: EXPERIMENTAL
Intervention: DHEP mouthwash (0.103% DHEP in aqueous solution)
Number of subjects: 80

Group type: COMPARATOR
Intervention: diclofenac mouthwash (0.074% free diclofenac in aqueous solution)
Number of subjects: 80
Study: 19258147

Group type: EXPERIMENTAL
Intervention: Immediate Active Motion Protocol (IAMP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional Immobilization
Number of subjects: 50
Study: 17332211

Group type: EXPERIMENTAL
Intervention: Children < 2 years of age with bilateral acute otitis media
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Children >= 2 years of age with unilateral acute otitis media
Number of subjects: 824
Study: 15710792

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 12136454

Group type: EXPERIMENTAL
Intervention: High tourniquet pressure (400 mmHg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Low tourniquet pressure (100 mmHg above systolic pressure)
Number of subjects: 86
Study: 10072097

Group type: EXPERIMENTAL
Intervention: Strength test (two sets of 12 repetitions at 12-repetition maximum and four sets of 5 repetitions at 5-repetition maximum)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Strength training program (8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sedentary group (control)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Trained group
Number of subjects: 32
Study: 7674236

Group type: EXPERIMENTAL
Intervention: Tenidap (120 mg/day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tenidap
Number of subjects: 32
Study: 2402930

Group type: EXPERIMENTAL
Intervention: Ambroxol
Number of subjects: 137

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 137
Study: 7016643

Group type: EXPERIMENTAL
Intervention: Propranolol (3 mg/3 min and 0.8 mg/min)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (no adrenergic blockade)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Phentolamine (5 mg stat and 0.5 mg/min)
Number of subjects: 7
Study: 31434140

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated administration of ketamine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketamine (various applications: intravenous, subcutaneous, intramuscular, intranasal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0
Study: 29125216

Group type: EXPERIMENTAL
Intervention: Pēpi‐Pod sleep space programme
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 240
Study: 27098290

Group type: EXPERIMENTAL
Intervention: 0.1 g·kg‐1BM of NaHCO3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.2 g·kg‐1BM of NaHCO3
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 0.3 g·kg‐1BM of NaHCO3
Number of subjects: 16
Study: 23998788

Group type: EXPERIMENTAL
Intervention: Antenatal vitamin K1 administration (Group A)
Number of subjects: 90

Group type: COMPARATOR
Intervention: No antenatal vitamin K1 administration (Group B)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Healthy full term newborns (Group C)
Number of subjects: 90
Study: 23089675

Group type: EXPERIMENTAL
Intervention: Brief group alcohol intervention (two 45-min sessions based on motivational interviewing techniques)
Number of subjects: 668

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 668
Study: 21095491

Group type: EXPERIMENTAL
Intervention: Test formulation (recombinant human erythropoietin 4000 IU SC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference formulation (recombinant human erythropoietin 4000 IU SC)
Number of subjects: 20
Study: 18297183

Group type: EXPERIMENTAL
Intervention: Behavioral intervention (six hour intervention delivered in two sessions on two consecutive Saturdays)
Number of subjects: 832

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 832
Study: 15705086

Group type: EXPERIMENTAL
Intervention: Tolterodine (antimuscarinic drug)
Number of subjects: 0
Study: 12939945

Group type: EXPERIMENTAL
Intervention: Reamberine and citotoflavine (metabolic antihypoxants)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Perftoran and cytoflavin (added to therapy scheme)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison group (intensive therapy without metabolic antihypoxants)
Number of subjects: 44
Study: 11004048

Group type: EXPERIMENTAL
Intervention: 26-gauge Atraucan needle
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: 25-gauge Quincke needle
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: 24-gauge Gertie Marx (GM) needle
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: 24-gauge Sprotte needle
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: 25-gauge Whitacre needle
Number of subjects: 1002
Study: 8837981

Group type: EXPERIMENTAL
Intervention: terfenadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 1421975

Group type: EXPERIMENTAL
Intervention: Salvia miltiorrhizae (SM) plus vitamin C, ATP, CoA (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vitamin C, ATP, CoA (n = 30)
Number of subjects: 60
Study: 6536840

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of potassium chloride
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of potassium/magnesium chloride
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of potassium-(D,L)-aspartate
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of potassium/magnesium-(D,L)-aspartate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 8
Study: 3539027

Group type: EXPERIMENTAL
Intervention: Maternal or banked breast milk
Number of subjects: 186

Group type: COMPARATOR
Intervention: Artificial preterm formula
Number of subjects: 186
Study: 31374218

Group type: EXPERIMENTAL
Intervention: Suvorexant (10 mg week 1, 20 mg week 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29916560

Group type: EXPERIMENTAL
Intervention: Heart failure medications (specific drugs not mentioned)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recruitment methods for randomized clinical trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing medications thoroughly in both sexes
Number of subjects: 0
Study: 27343887

Group type: EXPERIMENTAL
Intervention: Parent Training
Number of subjects: 180

Group type: COMPARATOR
Intervention: Parent Education
Number of subjects: 180
Study: 24355874

Group type: EXPERIMENTAL
Intervention: Early plasma Angiopoietin‐2 (Ang‐2) levels
Number of subjects: 115
Study: 22863644

Group type: EXPERIMENTAL
Intervention: Reconnective Healers
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Reiki Masters
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 81
Study: 20398558

Group type: EXPERIMENTAL
Intervention: TAP technique
Number of subjects: 127

Group type: COMPARATOR
Intervention: Simple stenting
Number of subjects: 127
Study: 18713912

Group type: EXPERIMENTAL
Intervention: bupivacaine‐clonidine 150 microg (BC group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: bupivacaine‐sufentanil (BS group)
Number of subjects: 96

Group type: COMPARATOR
Intervention: bupivacaine‐sufentanil‐clonidine 75 microg (BSC group)
Number of subjects: 96
Study: 15673383

Group type: EXPERIMENTAL
Intervention: Ablation guided by pace mapping of Koch's triangle (Group 2)
Number of subjects: 909

Group type: COMPARATOR
Intervention: Conventional slow pathway ablation (Group 1)
Number of subjects: 909
Study: 12950571

Group type: EXPERIMENTAL
Intervention: Diamond-coated ultrasonic retrotips (DC)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Zirconium nitride-coated retrotips (KiS)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Stainless steel tip (CT-5)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Positive controls
Number of subjects: 85

Group type: COMPARATOR
Intervention: Negative controls
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Three experimental groups (DC, KiS, CT-5)
Number of subjects: 85
Study: 11095320

Group type: EXPERIMENTAL
Intervention: Pantoprazole 10 mg
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg
Number of subjects: 603

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 603
Study: 8870066

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: d-amphetamine (d-AMP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone (TRZ)
Number of subjects: 0
Study: 1410147

Group type: EXPERIMENTAL
Intervention: Tryptophan-deficient amino acid mixture (4.5 hours before morphine administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine (10 mg intramuscularly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tryptophan-containing mixture (control)
Number of subjects: 0
Study: 3904654

Group type: EXPERIMENTAL
Intervention: Potassium chloride, 24 to 96 mEq/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Triamterene, 50 to 200 mg daily
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Triamterene added to diuretic therapy
Number of subjects: 16
Study: 31411147

Group type: EXPERIMENTAL
Intervention: Gout Central app (n=36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Dietary app (n=36)
Number of subjects: 72
Study: 29602537

Group type: EXPERIMENTAL
Intervention: Gap Balancing (GB)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Measured Resection (MR)
Number of subjects: 91
Study: 27383825

Group type: EXPERIMENTAL
Intervention: Web-based cognitive training in addition to standard rehabilitation (24 sessions for 8 weeks)
Number of subjects: 20
Study: 24297792

Group type: EXPERIMENTAL
Intervention: Carbohydrate beverage
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Protein beverage
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lipid beverage
Number of subjects: 16
Study: 22442101

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotics
Number of subjects: 227

Group type: COMPARATOR
Intervention: First-generation antipsychotics
Number of subjects: 227
Study: 21232723

Group type: EXPERIMENTAL
Intervention: Combination-facilitated group (abciximab with half-dose reteplase)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Abciximab-facilitated group
Number of subjects: 637

Group type: COMPARATOR
Intervention: Primary PCI group (no pre-treatment)
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Post-PCI corrected TIMI frame count
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Post-PCI TIMI flow grade 3
Number of subjects: 637

Group type: EXPERIMENTAL
Intervention: Post-PCI myocardial blush grade 2/3
Number of subjects: 637
Study: 18081147

Group type: EXPERIMENTAL
Intervention: Alexandrite laser treatment
Number of subjects: 38
Study: 15605283

Group type: EXPERIMENTAL
Intervention: Enuresis alarms (group 1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oral desmopressin 400 mug (group 2)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Combined therapy (group 3)
Number of subjects: 105
Study: 11828811

Group type: EXPERIMENTAL
Intervention: Long-acting beta 2-agonists
Number of subjects: 0
Study: 11265378

Group type: EXPERIMENTAL
Intervention: MPPWs recording in patients with sensorineural hearing loss
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: MPPWs recording in patients with retrocochlear hearing loss
Number of subjects: 65

Group type: COMPARATOR
Intervention: Normal hearing subjects
Number of subjects: 65
Study: 9238877

Group type: EXPERIMENTAL
Intervention: Amine fluoride dentifrice
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sodium fluoride dentifrice
Number of subjects: 24

Group type: COMPARATOR
Intervention: Mouthrinsing with 20 ml distilled water
Number of subjects: 24

Group type: COMPARATOR
Intervention: No mouthrinsing after spitting out
Number of subjects: 24
Study: 1534742

Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ipratropium
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 36
Study: 3881160

Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (homogeneous subgroup)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radical mastectomy (homogeneous subgroup)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (central or medial tumors)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radical mastectomy (central or medial tumors)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Extended radical mastectomy (lateral tumors)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Radical mastectomy (lateral tumors)
Number of subjects: 123
Study: 29621979

Group type: EXPERIMENTAL
Intervention: Operative treatment with volar locking plate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-operative treatment with cast immobilization
Number of subjects: 0
Study: 28836987

Group type: EXPERIMENTAL
Intervention: High-intensity training group (HITG), 70%-80% HRR
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Middle-intensity training group (MITG), 50%-70% HRR
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Light-intensity training group (LITG), 40%-50% HRR
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 48
Study: 25462652

Group type: EXPERIMENTAL
Intervention: Alcohol only intervention
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Integrated intervention
Number of subjects: 311

Group type: COMPARATOR
Intervention: Referral-only control
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Depressed mood only intervention
Number of subjects: 311
Study: 23414176

Group type: EXPERIMENTAL
Intervention: A time limited CBT informed psychological intervention for anxiety in bipolar disorder (AIBD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 21656179

Group type: EXPERIMENTAL
Intervention: Split-dose polyethylene glycol (PEG) (2 L/2 L)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Split-dose aqueous sodium phosphate (NaP) (45 mL/45 mL, 12 h apart)
Number of subjects: 207
Study: 18321744

Group type: EXPERIMENTAL
Intervention: BDP/formoterol 100 microg/6 microg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Formoterol 6 microg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 16926616

Group type: EXPERIMENTAL
Intervention: Community-based anger management group
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 123
Study: 14610480

Group type: EXPERIMENTAL
Intervention: Active therapy (grass pollen immunotherapy)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 10731916

Group type: EXPERIMENTAL
Intervention: SS-cream 0.05 gm
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SS-cream 0.10 gm
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SS-cream 0.15 gm
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SS-cream 0.20 gm
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo 0.10 gm
Number of subjects: 53
Study: 9188946

Group type: EXPERIMENTAL
Intervention: Active treatment (specific immunotherapy)
Number of subjects: 656

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 656
Study: 12959296

Group type: EXPERIMENTAL
Intervention: 75 mg tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 250 mg tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 500 mg (2 x 250 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 500 mg immediately following a standard meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fasted state
Number of subjects: 12